PH15850A - Pharmaceutical formulations containing prostaglandin compounds - Google Patents

Pharmaceutical formulations containing prostaglandin compounds

Info

Publication number
PH15850A
PH15850A PH22508A PH22508A PH15850A PH 15850 A PH15850 A PH 15850A PH 22508 A PH22508 A PH 22508A PH 22508 A PH22508 A PH 22508A PH 15850 A PH15850 A PH 15850A
Authority
PH
Philippines
Prior art keywords
pharmaceutical formulations
formulations containing
prostaglandin compounds
containing prostaglandin
compounds
Prior art date
Application number
PH22508A
Other languages
English (en)
Inventor
Ian Seymour Waats
Peter Hugh Marsden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH15850A publication Critical patent/PH15850A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH22508A 1978-05-17 1979-05-16 Pharmaceutical formulations containing prostaglandin compounds PH15850A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17

Publications (1)

Publication Number Publication Date
PH15850A true PH15850A (en) 1983-04-13

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22508A PH15850A (en) 1978-05-17 1979-05-16 Pharmaceutical formulations containing prostaglandin compounds

Country Status (28)

Country Link
US (1) US4335139A (nl)
EP (1) EP0005768B1 (nl)
JP (1) JPS54163809A (nl)
KR (1) KR830000527B1 (nl)
AT (2) AT365926B (nl)
AU (1) AU525695B2 (nl)
BE (1) BE876296A (nl)
CA (1) CA1141661A (nl)
CH (1) CH641044A5 (nl)
CS (1) CS214798B2 (nl)
DE (2) DE2920020A1 (nl)
DK (1) DK156004C (nl)
ES (1) ES480597A1 (nl)
FI (1) FI68359C (nl)
FR (1) FR2425856A1 (nl)
GR (1) GR68452B (nl)
HU (1) HU182746B (nl)
IL (1) IL57298A (nl)
IT (1) IT1116840B (nl)
LU (1) LU81272A1 (nl)
MC (1) MC1265A1 (nl)
NL (1) NL7903871A (nl)
NZ (1) NZ190462A (nl)
PH (1) PH15850A (nl)
PL (1) PL134004B1 (nl)
SE (1) SE450930B (nl)
SU (1) SU978715A3 (nl)
ZA (1) ZA787353B (nl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
AU623147B2 (en) * 1988-06-17 1992-05-07 Wellcome Foundation Limited, The Compounds for use in medicine
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
ATE424399T1 (de) * 2005-06-29 2009-03-15 Verisfield Uk Ltd Pharmazeutische zusammensetzungen von risperidon in wässriger lösung
JP5415771B2 (ja) 2006-02-03 2014-02-12 アクテリオン ワン エスエー 新規なエポプロステノール製剤およびその製造方法
ES2728785T3 (es) 2007-09-07 2019-10-28 United Therapeutics Corp Soluciones tampón con actividad bactericida selectiva contra las bacterias gramnegativas y métodos para usarlas
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
SE443716B (sv) * 1977-05-20 1986-03-10 Wellcome Found Sett att framstella en farmaceutisk beredning for inhibering av blodplettsaggregation innehallande prostacyklin eller dihydroprostacyklin och en fosfodiesterasinhibitor

Also Published As

Publication number Publication date
PL134004B1 (en) 1985-07-31
ATA363479A (de) 1981-07-15
CA1141661A (en) 1983-02-22
FI791565A (fi) 1979-11-18
DK156004B (da) 1989-06-12
IL57298A0 (en) 1979-09-30
CH641044A5 (de) 1984-02-15
US4335139A (en) 1982-06-15
BE876296A (fr) 1979-11-16
JPS6358810B2 (nl) 1988-11-17
LU81272A1 (fr) 1979-12-07
JPS54163809A (en) 1979-12-26
FR2425856A1 (fr) 1979-12-14
AU4704279A (en) 1979-11-22
EP0005768A1 (en) 1979-12-12
NZ190462A (en) 1982-05-31
DK201879A (da) 1979-11-18
DE2966046D1 (en) 1983-09-15
GR68452B (nl) 1981-12-30
DE2920020A1 (de) 1979-11-29
MC1265A1 (fr) 1980-03-28
CS214798B2 (en) 1982-05-28
ATE4411T1 (de) 1983-08-15
ZA787353B (en) 1980-08-27
IT1116840B (it) 1986-02-10
SE7904284L (sv) 1979-11-18
IL57298A (en) 1983-09-30
ES480597A1 (es) 1980-08-16
DK156004C (da) 1989-11-06
FR2425856B1 (nl) 1982-06-25
SU978715A3 (ru) 1982-11-30
AU525695B2 (en) 1982-11-25
IT7949064A0 (it) 1979-05-16
PL215627A1 (nl) 1981-08-07
FI68359C (fi) 1985-09-10
NL7903871A (nl) 1979-11-20
HU182746B (en) 1984-03-28
EP0005768B1 (en) 1983-08-10
FI68359B (fi) 1985-05-31
AT365926B (de) 1982-02-25
DE2920020C2 (nl) 1988-09-01
SE450930B (sv) 1987-08-17
KR830000527B1 (ko) 1983-03-12

Similar Documents

Publication Publication Date Title
NO176550C (no) Fremgangsmåte for fremstilling av stabile, pressede, farmasöytiske formuleringer inneholdende en forbindelse
ATE137963T1 (de) Lh-rh-analoga enthaltende formulierungen
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
PH15850A (en) Pharmaceutical formulations containing prostaglandin compounds
DE3460035D1 (en) 1'-ethoxycarbonyloxyethyl ester of valproic acid, its preparation and formulations containing it
ES551886A0 (es) Procedimiento para la obtencion de s.s -dioxido de 3-acetilamino-4-metoxi-benzoisotiazol
GB2021581A (en) Stabilisation of PGl2 derivatives
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
ES537558A0 (es) Un procedimiento para la preparacion del isomero r (dextrogiro)
AU560165B2 (en) Chromophoric peptides
IT1115160B (it) Procedimento per la preparazione di un agente scintillografico
IT1123731B (it) Procedimento per la preparazione di 1,2,3-tiadiazol-5-il-uree
JPS5337690A (en) Novel pyridinophans their preparation and racemization catalysis containing the same for amino acids
IT7823273A0 (it) Procedimento per la preparazione di ciclacillina anidra.
TH4273EX (th) สารผสมที่ใช้เป็นสารพ่นละอองละเอียดต่อต้านการขับเหงื่อ
GB2162746A (en) Antiacidotic medicinal agent
IT8722575A0 (it) Procedimento per la preparazione di fluorossi fluoro composti.
IT7826382A0 (it) Procedimento per la preparazione di prostaciclina e di composti analoghi.
PT76773B (en) Process for the preparation of an aqueous pharmaceutical composition with salbutamol base
IT1100093B (it) Procedimento per la preparazione di 1,3-diammidi

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 14